Relationship between codon 249 mutation in exon 7 of p53 gene and diagnosis of hepatocellular carcinoma

Archives of Medical Science

Volumn 6, Issue 3, 2010, Pages 348-355

  El Din, Hesham Gamal ^a   Ghafar, Nagwa Abdel ^a   Saad, Nevine E ^a   Aziz, Mona ^b   Rasheed, Dina ^b   Hassan, Eman Mahmoud ^a  

^a NATIONAL RESEARCH CENTRE   (Egypt)

^b CAIRO UNIVERSITY   (Egypt)

Author keywords

Hepatitis B virus; Hepatitis C virus; Hepatocellular carcinoma; HSP70; p53

Indexed keywords

ALPHA FETOPROTEIN;

ADULT; AGED; ARTICLE; BLOOD; CLINICAL ARTICLE; CODON; CONTROLLED STUDY; DNA EXTRACTION; EGYPT; EXON; FEMALE; GENE; GENETIC POLYMORPHISM; GENOTYPE; HEAT SHOCK PROTEIN 70 GENE 1; HEAT SHOCK PROTEIN 70 GENE 2; HEPATITIS B; HEPATITIS C; HUMAN; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER FUNCTION TEST; MALE; POINT MUTATION; POLYMERASE CHAIN REACTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; TUMOR SUPPRESSOR GENE;

EID: 77954288273     PISSN: 17341922     EISSN: None     Source Type: Journal    
DOI: 10.5114/aoms.2010.14254     Document Type: Article

References (17)

1. Machida K, Cheng KT, Sung VM, et al. Hepatitis C virus induces a mutator phenotype: enhanced mutations of immunoglobulin and protooncogenes. Proc Natl Acad Sci USA 2004; 101: 4262-7. (Pubitemid 38405917)
2. Singh R, Kølvraa S, Bross P, et al. Association between low self-rated health and heterozygosity for -110A > C polymorphism in the promoter region of HSP70-1 in aged Danish twins. Biogerontology 2004; 8: 169-76.
3. Chi TY, Chen GG, Ho LK, Lai PB. Establishment of a doxycycline-regulated cell line with inducible, doubly-stable expression of the wild-type p53 gene from p53-deleted hepatocellular carcinoma cells. Cancer Cell Int 2005; 5: 27.
4. Guan YS, La Z, Yang L, He Q, Li P. p53 gene in treatment of hepatic carcinoma: Status quo. World J Gastroenterol 2007; 13: 985-92. (Pubitemid 46510997)
5. Huang XH, Sun LH, Lu DD, et al. Codon 249 mutation in exon 7 of p53 gene in plasma DNA: maybe a new early diagnostic marker of hepatocellular carcinoma in Qidong risk area, China. World J Gastroenterol 2003; 9: 692-5.
6. Ciocca DR, Calderwood SK. Heat shock proteins in cancer: diagnostic, prognostic, predictive, and treatment implications. Cell Stress Chaperones 2005; 10: 86-103.
7. Joo M, Chi JG, Lee H. Expressions of HSP70 and HSP27 in hepatocellular carcinoma. J Korean Med Sci 2005; 20: 829-34. (Pubitemid 41587241)
8. Sherif IA, Abdelwahab SF, Mohamed MM, et al. T cells are depleted in HCV-induced hepatocellular carcinoma patients: possible role of apoptosis and p53. Retrovirology 2006; 3 (Suppl 1): S32.
9. Hassan MM, Zaghloul AS, El-Serag HB, et al. The role of hepatitis C in hepatocellular carcinoma: a case control study among Egyptian patients. J Clin Gastroenterol 2001; 33: 123-6.
10. Yu MC, Yuan JM, Govindarajan S, Ross RK. Epidemiology of hepatocellular carcinoma. Can J Gastroenterol 2000; 14: 703-9.
11. Kirk GD, Camus-Randon AM, Mendy M, et al. Ser-249 p53 mutations in plasma DNA of patients with hepatocellular carcinoma from The Gambia. J. Natl Cancer Inst 2000; 92: 148-53. (Pubitemid 30089872)
12. ShimizuY, Zhu JJ, Han F, Ishikawa T, Oda H. Different frequencies of p53 codon-249 hot-spot mutations in hepatocellular carcinomas in Jiang-su province of China. Int J Cancer 1999; 82: 187-90. (Pubitemid 29293775)
13. Sohn S, Jaitovitch-Groisman I, Benlimame N, Galipeau J, Batist G, Alaoui-Jamli MA. Retroviral expression of the hepatitis B virus x gene promotes liver cell susceptibility to carcinogen-induced site specific mutagenesis. Mutat Res 2000; 460: 17-28.
14. Mona SK, Ann AF, Ossama AK, Moones AO. Thesis: The prevelance of p53 gene mutation in hepatocellular carcinoma in Egypians, M.D. degree in Clinical and Chemical Pathology. Faculty of Medicine Menoufiya University. 2002.
15. Stern MC, Umbach DM, Yu MC, London SJ, Zhang ZQ, Taylor JA. Hepatitis B, aflatoxin B1, and p53 codon 249 mutation in hepatocellular carcinomas from Guangxi, people's Republic of China, and a meta-analysis of existing studies. Cancer Epidemiol Biomark Prevent 2001; 10: 617-25.
16. Kao JH, Chen PJ, Lai MY, Chen DS. Occult hepatitis B virus infection and clinical outcomes of patients with chronic hepatitis C. J Clin Microbiol 2000; 40: 4068-71.
17. Chuma M, Sakamoto M, Yamazaki K, et al. Expression profiling in multistage hepatocarcinogenesis: identification of HSP70 as a molecular marker of early hepatocellular carcinoma. Hepatology 2002; 37: 198-207.